Key Points
- Insider Bruce Hiscock bought 150 shares of Bioventix on Nov 25 at an average of GBX 2,071 (total £3,106.50), after purchasing 119 shares on Oct 27 at GBX 2,009 (total £2,390.71).
- Shares opened at GBX 2,025 with a 50-day MA of GBX 2,265.05 and 200-day MA of GBX 2,517.68; the 12‑month range is GBX 1,750–3,850 and the company has a market cap of £105.81M and a P/E of 14.13.
- Bioventix reported quarterly EPS of GBX 145.27, with a net margin of 59.51% and ROE of 69.09%, and analysts project full‑year EPS of about 166.31 GBX.
Bioventix PLC (LON:BVXP - Get Free Report) insider Bruce Hiscock acquired 150 shares of Bioventix stock in a transaction on Tuesday, November 25th. The stock was acquired at an average cost of GBX 2,071 per share, for a total transaction of £3,106.50.
Bruce Hiscock also recently made the following trade(s):
- On Monday, October 27th, Bruce Hiscock bought 119 shares of Bioventix stock. The stock was acquired at an average price of GBX 2,009 per share, with a total value of £2,390.71.
Bioventix Stock Performance
Shares of LON:BVXP opened at GBX 2,025 on Thursday. The business has a fifty day moving average of GBX 2,265.05 and a 200-day moving average of GBX 2,517.68. Bioventix PLC has a twelve month low of GBX 1,750 and a twelve month high of GBX 3,850. The firm has a market cap of £105.81 million, a PE ratio of 14.13 and a beta of 0.35.
Bioventix (LON:BVXP - Get Free Report) last issued its quarterly earnings data on Monday, October 27th. The biotechnology company reported GBX 145.27 EPS for the quarter. Bioventix had a net margin of 59.51% and a return on equity of 69.09%. On average, analysts anticipate that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.
About Bioventix
(
Get Free Report)
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
